Author | Dawn L. Hershman, MD, MS | OncLive

Author | Dawn L. Hershman, MD, MS

Articles

Dr. Hershman on Misconceptions With the TAILORx Trial in HR+/HER2- Breast Cancer

March 13, 2020

Video

Dawn L. Hershman, MD, MS, discusses the design of the phase III TAILORx trial in hormone receptor (HR)–positive, HER2-negative breast cancer.

Dr. Hershman on the Equivalency of Biosimilars and Biologics

September 06, 2019

Video

Dawn L. Hershman, MD, MS, professor of Medicine and Epidemiology, Columbia University Medical Center, leader of the breast cancer program at NewYork-Presbyterian/Columbia University Irving Medical Center, discusses the equivalency of biosimilars and biologics.

x